1. Home
  2. OGN vs CGAU Comparison

OGN vs CGAU Comparison

Compare OGN & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CGAU
  • Stock Information
  • Founded
  • OGN 1923
  • CGAU 2002
  • Country
  • OGN United States
  • CGAU Canada
  • Employees
  • OGN N/A
  • CGAU N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CGAU Precious Metals
  • Sector
  • OGN Health Care
  • CGAU Basic Materials
  • Exchange
  • OGN Nasdaq
  • CGAU Nasdaq
  • Market Cap
  • OGN 2.7B
  • CGAU 2.4B
  • IPO Year
  • OGN N/A
  • CGAU N/A
  • Fundamental
  • Price
  • OGN $7.71
  • CGAU $12.03
  • Analyst Decision
  • OGN Hold
  • CGAU Buy
  • Analyst Count
  • OGN 4
  • CGAU 3
  • Target Price
  • OGN $15.75
  • CGAU $14.17
  • AVG Volume (30 Days)
  • OGN 9.3M
  • CGAU 1.5M
  • Earning Date
  • OGN 11-10-2025
  • CGAU 10-28-2025
  • Dividend Yield
  • OGN 1.04%
  • CGAU 1.67%
  • EPS Growth
  • OGN N/A
  • CGAU 236.39
  • EPS
  • OGN 1.91
  • CGAU 1.60
  • Revenue
  • OGN $6,301,000,000.00
  • CGAU $1,285,392,000.00
  • Revenue This Year
  • OGN N/A
  • CGAU $9.10
  • Revenue Next Year
  • OGN $0.65
  • CGAU $13.13
  • P/E Ratio
  • OGN $4.03
  • CGAU $7.50
  • Revenue Growth
  • OGN N/A
  • CGAU 2.66
  • 52 Week Low
  • OGN $6.18
  • CGAU $5.41
  • 52 Week High
  • OGN $17.23
  • CGAU $12.80
  • Technical
  • Relative Strength Index (RSI)
  • OGN 46.71
  • CGAU 57.32
  • Support Level
  • OGN $7.38
  • CGAU $11.51
  • Resistance Level
  • OGN $7.88
  • CGAU $12.56
  • Average True Range (ATR)
  • OGN 0.41
  • CGAU 0.44
  • MACD
  • OGN 0.19
  • CGAU -0.01
  • Stochastic Oscillator
  • OGN 90.88
  • CGAU 63.51

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CGAU Centerra Gold Inc.

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

Share on Social Networks: